This elevation in ECS “tone” and the resultant CB1R overactivation play contributory roles in the onset of kidney damage, inflammatory responses, and lipid accumulation [20], with pharmacological blockade and genetic deletion of renal CB1R shown to mitigate the damage [20,22,28]. The gene discussed is CNR1; the disease is Nephropathy.